PolyPid Correlations

PYPD Stock

USD 4.58 0.06 1.33%

The current 90-days correlation between PolyPid and Annovis Bio is 0.24 (i.e., Modest diversification). The correlation of PolyPid is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

PolyPid Correlation With Market

Very poor diversification

The correlation between PolyPid and DJI is 0.86 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PolyPid and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with PolyPid Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

Moving together with PolyPid Stock

0.7	DSGN	Design Therapeutics	Pair Corr
0.73	ENGN	enGene Holdings Common	Pair Corr
0.67	63E	ONWARD MEDICAL BV	Pair Corr
0.83	IMMP	Immutep Ltd ADR	Pair Corr
0.9	MRKR	Marker Therapeutics	Pair Corr
0.73	RCKT	Rocket Pharmaceuticals	Pair Corr
0.73	AVE	Avecho Biotechnology	Pair Corr
0.85	ANNX	Annexon	Pair Corr
0.74	SLDB	Solid Biosciences LLC	Pair Corr
0.67	AVCR	Avricore Health	Pair Corr
0.83	BOLT	Bolt Biotherapeutics	Pair Corr
0.74	TNGX	Tango Therapeutics	Pair Corr
0.71	CADL	Candel Therapeutics	Pair Corr

Moving against PolyPid Stock

0.86	DWTX	Dogwood Therapeutics	Pair Corr
0.86	ABP	Abpro Holdings	Pair Corr
0.81	GNLX	Genelux Common	Pair Corr
0.77	IMRN	Immuron Ltd ADR	Pair Corr
0.77	KURA	Kura Oncology	Pair Corr
0.76	EDIT	Editas Medicine	Pair Corr
0.69	LYRA	Lyra Therapeutics	Pair Corr
0.56	QSI	QuantumSi	Pair Corr
0.49	EVGN	Evogene	Pair Corr
0.86	MREO	Mereo BioPharma Group	Pair Corr
0.83	ACXP	Acurx Pharmaceuticals LLC	Pair Corr
0.72	PRQR	ProQR Therapeutics	Pair Corr
0.64	MBIO	Mustang Bio	Pair Corr
0.45	PROK	ProKidney Corp	Pair Corr
0.32	AURA	Aura Biosciences	Pair Corr

Related Correlations Analysis

	ANVS	RVPH	BCAB	EVAX	CELU	MAIA	VERU	ATNM	BTAI	PDSB
ANVS		0.36	0.46	0.31	0.37	-0.29	-0.41	0.57	0.55	-0.06	ANVS
RVPH	0.36		0.71	0.79	0.75	-0.66	0.13	0.47	0.6	0.19	RVPH
BCAB	0.46	0.71		0.68	0.66	-0.79	-0.13	0.56	0.35	-0.15	BCAB
EVAX	0.31	0.79	0.68		0.6	-0.73	-0.04	0.53	0.68	0.41	EVAX
CELU	0.37	0.75	0.66	0.6		-0.63	0.13	0.11	0.6	-0.08	CELU
MAIA	-0.29	-0.66	-0.79	-0.73	-0.63		0.35	-0.45	-0.33	0.13	MAIA
VERU	-0.41	0.13	-0.13	-0.04	0.13	0.35		-0.4	0.03	0.26	VERU
ATNM	0.57	0.47	0.56	0.53	0.11	-0.45	-0.4		0.35	0.25	ATNM
BTAI	0.55	0.6	0.35	0.68	0.6	-0.33	0.03	0.35		0.49	BTAI
PDSB	-0.06	0.19	-0.15	0.41	-0.08	0.13	0.26	0.25	0.49		PDSB
	ANVS	RVPH	BCAB	EVAX	CELU	MAIA	VERU	ATNM	BTAI	PDSB

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EVAX	+ 0.79	RVPH
CELU	+ 0.75	RVPH
BCAB	+ 0.71	RVPH
EVAX	+ 0.68	BCAB
BTAI	+ 0.68	EVAX
CELU	+ 0.66	BCAB

High negative correlations

MAIA	- 0.79	BCAB
MAIA	- 0.73	EVAX
MAIA	- 0.66	RVPH
MAIA	- 0.63	CELU
ATNM	- 0.45	MAIA
VERU	- 0.41	ANVS

Risk-Adjusted Indicators

There is a big difference between PolyPid Stock performing well and PolyPid Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PolyPid's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANVS	5.12	0.57	0.10	0.82	5.10	(6.27)	14.79	(9.57)	41.06
RVPH	5.67	(0.69)	0.00	(0.38)	0.00	0.00	10.71	(9.68)	57.05
BCAB	7.30	(1.15)	0.00	0.63	0.00	0.00	15.28	(18.87)	66.15
EVAX	4.59	(0.58)	0.00	(1.53)	0.00	0.00	9.43	(8.42)	37.88
CELU	3.58	(0.44)	0.00	(0.22)	0.00	0.00	10.29	(8.15)	26.97
MAIA	5.79	1.18	0.14	12.84	7.23	(6.06)	12.60	(10.75)	45.94
VERU	2.99	0.00	0.00	0.08	0.00	0.00	6.07	(7.92)	22.62
ATNM	3.03	(0.23)	0.00	(0.31)	0.00	0.00	5.84	(5.43)	20.75
BTAI	4.12	(0.16)	0.00	(0.26)	0.00	0.00	9.42	(8.05)	25.30
PDSB	4.14	(0.42)	0.00	(0.11)	0.00	0.00	8.08	(8.41)	27.78

PolyPid Corporate Management

Ori Warshavsky	Chief US	Profile
MD MBA	Chief Officer	Profile
Dikla Akselbrad	Chief Officer	Profile
Malka Reichart	Scientific Director	Profile
Rivi Levari	Vice Resource	Profile
Orna Blum	Legal Counsel	Profile
JeanMarc PharmD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC